UW Bioengineering Assistant Professor Deok-Ho Kim and Charles Murry have received one of three 2016 ITHS Collaboration Innovation Awards. The award encourages the development of new interdisciplinary collaborations that address critical transitions in translational research.
In this role, Assistant Professor Deok-Ho Kim will support EMBS on teleconferences or at scheduled meetings, and submit representative reports to IEEE EMBS leadership.
Deok-Ho Kim’s “Self-assembling peptides for stem cell and tissue engineering” featured on Biomaterials Science cover
Deok-Ho Kim and collaborators examine the potential of self-assembling peptides (SAPs) in conjunction with stem cells to improve the repair of damaged tissues.
UW Bioengineering Assistant Professor Deok-Ho Kim and collaborators have demonstrated the ability of electroconductive nanopatterned substrates to enhance the maturation and differentiation of skeletal muscle cells.
Assistant Professor Deok-Ho Kim has been named a 2015 Young Innovator of Cellular and Molecular Bioengineering (CMBE) by the Biomedical Engineering Society. Dr. Kim was recognized for the development of a nanopatterned human induced pluripotent stem cell (iPSC)-derived model of a dystrophin-null cardiomyopathic phenotype.
This May marks the 10th anniversary of the UW’s Coulter Translational Research Partnership in Biomedical Engineering, which has helped propel dozens of UW inventions from the lab toward clinical use. We profile one of Coulter’s recent successes: a platform for growing cardiac cells for drug toxicity testing. Researchers in BioE’s Deok-Ho Kim’s lab developed the technology, which was recently spun out to the start-up NanoSurface Biomedical.
UW Bioengineering Assistant Professor Deok-Ho Kim recently was appointed to the editorial board of the academic journal Theranostics. The journal, which has an impact factor of 7.806, is one of the leading journals in the field of regenerative medicine and therapeutic applications.
UW Bioengineering Assistant Professor Deok-Ho Kim is a 2013 recipient of the Korean-American Scientists and Engineers Association (KSEA) Young Investigator Award.
Deok-Ho Kim has received a $250,000 Proof of Concept grant from the Life Sciences Discovery Fund, which will further development of a micro/nano-engineered cardiotoxicity assay.